M L Galantino1, S T Eke-Okoro, T W Findley, D Condoluci. 1. Neuromusculoskeletal Institute, Department of Physical Medicine and Rehabilitation, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford 08084, USA. galantinoml@stockton.edu
Abstract
OBJECTIVES: The main objective of this study was to test the hypothesis that low-voltage non-invasive electroacupuncture will improve the condition of neuropathic human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. DESIGN: A prospective study using HIV/AIDS patients who had antiretroviral drug-induced neuropathy. Eleven patients were enrolled, but complete data was obtained from only 7. Non-invasive skin electrodes were placed on leg acupuncture points BL60, ST36, K1, LIV3, and low-voltage current passed for 20 minutes every day for 30 days. Patients were assessed preintervention and postintervention with MOS-HIV 30-item instrument questionnaire and tibial H-reflex was similarly recorded from the right calf muscle. RESULTS: There was improvement in the condition of all 7 patients. They felt much better and reported feelings of increased physical strength. Outcomes on MOS-HIV 30-item instrument showed significant overall improvement in functional activities (pre 33+/-10, post 38.4+/-9.6, p = 0.02 MANOVA). This was confirmed by postintervention H-reflex parameters; H-max and direct muscle response (M-response) amplitudes were potentiated in relation to pretreatment values (H-max: pre = 1.19+/-1.2, post = 2.68+/-1.9, p<0.05; M-response: pre = 0.93+/-1.1, post = 2.34+/-1.8, p<0.05); M-response latency decreased in relation to pretreatment value (pre = 9.7+/-1.8, post = 7.8+/-1.9, p<0.01). CONCLUSION: The results support the hypothesis that low-voltage electroacupuncture will improve the condition of the neuropathic HIV/AIDS patient.
OBJECTIVES: The main objective of this study was to test the hypothesis that low-voltage non-invasive electroacupuncture will improve the condition of neuropathic human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. DESIGN: A prospective study using HIV/AIDSpatients who had antiretroviral drug-induced neuropathy. Eleven patients were enrolled, but complete data was obtained from only 7. Non-invasive skin electrodes were placed on leg acupuncture points BL60, ST36, K1, LIV3, and low-voltage current passed for 20 minutes every day for 30 days. Patients were assessed preintervention and postintervention with MOS-HIV 30-item instrument questionnaire and tibial H-reflex was similarly recorded from the right calf muscle. RESULTS: There was improvement in the condition of all 7 patients. They felt much better and reported feelings of increased physical strength. Outcomes on MOS-HIV 30-item instrument showed significant overall improvement in functional activities (pre 33+/-10, post 38.4+/-9.6, p = 0.02 MANOVA). This was confirmed by postintervention H-reflex parameters; H-max and direct muscle response (M-response) amplitudes were potentiated in relation to pretreatment values (H-max: pre = 1.19+/-1.2, post = 2.68+/-1.9, p<0.05; M-response: pre = 0.93+/-1.1, post = 2.34+/-1.8, p<0.05); M-response latency decreased in relation to pretreatment value (pre = 9.7+/-1.8, post = 7.8+/-1.9, p<0.01). CONCLUSION: The results support the hypothesis that low-voltage electroacupuncture will improve the condition of the neuropathic HIV/AIDSpatient.
Authors: Ting Bao; Olga Goloubeva; Colleen Pelser; Neil Porter; James Primrose; Lisa Hester; Mariola Sadowska; Rena Lapidus; Michelle Medeiros; Lixing Lao; Susan G Dorsey; Ashraf Z Badros Journal: Integr Cancer Ther Date: 2014-05-26 Impact factor: 3.279
Authors: Ting Bao; Andrew D Seidman; Lauren Piulson; Emily Vertosick; Xi Chen; Andrew J Vickers; Victoria S Blinder; Wanqing I Zhi; Qing Li; Linda T Vahdat; Maura N Dickler; Mark E Robson; Jun J Mao Journal: Eur J Cancer Date: 2018-07-13 Impact factor: 9.162
Authors: R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn Journal: Clin Infect Dis Date: 2017-10-30 Impact factor: 9.079
Authors: M Rostock; K Jaroslawski; C Guethlin; R Ludtke; S Schröder; H H Bartsch Journal: Evid Based Complement Alternat Med Date: 2013-08-28 Impact factor: 2.629